In recent years, it has been established that TG2 plays a key role in regulating the balance of such important processes as apoptosis and autophagy, regulating the survival of cancer cells, and, as a result, can be an innovative biomarker and therapeutic target in various types of cancer. This evidence concerns the gene TGM2 and cancer.